Mumbai,Sep 23 : Pharma major Lupin Limited (Lupin) has announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection carried out at its Tarapur manufacturing (API) facility.
The inspection was carried out between September 16 and 20, the company said in a filing with BSE.
The inspection at the Tarapur facility closed with three observations. The Company is confident of addressing them satisfactorily. (UNI)